NovaBridge Biosciences Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)
NovaBridge Biosciences (NBP) reported Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) of CNY 703.00 thousand for the 12-month period ending 2019-12-31, per its 20-F filed 2021-04-28.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss · last filed 2021-04-28
| Period end | Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss) 12 month |
|---|---|
| 2019-12-31 | 703.00K CNY 20-F · filed 2021-04-28 |